Meitav Investment House’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $75.6K | Hold |
40,000
| – | – | ﹤0.01% | 217 |
|
|
2025
Q1 | $37.2K | Hold |
40,000
| – | – | ﹤0.01% | 216 |
|
|
2024
Q4 | $48K | Hold |
40,000
| – | – | ﹤0.01% | 221 |
|
|
2024
Q3 | $50.8K | Hold |
40,000
| – | – | ﹤0.01% | 227 |
|
|
2024
Q2 | $44.8K | Sell |
40,000
-10,000
| -20% | -$11.2K | ﹤0.01% | 221 |
|
|
2024
Q1 | $91K | Sell |
50,000
-45,000
| -47% | -$81.9K | ﹤0.01% | 229 |
|
|
2023
Q4 | $74.6K | Hold |
95,000
| – | – | ﹤0.01% | 333 |
|
|
2023
Q3 | $67.5K | Hold |
95,000
| – | – | ﹤0.01% | 332 |
|
|
2023
Q2 | $142K | Hold |
95,000
| – | – | ﹤0.01% | 370 |
|
|
2023
Q1 | $193K | Buy |
+95,000
| New | +$193K | ﹤0.01% | 348 |
|